People diagnosed with liver cancer, pancreatic cancer, and other viral diseases such as Hepatitis could have a better option for treatment.
The company has made a REVOLUTIONARY discovery of a specific tumor marker on cancer and virally infected cells. Based on this finding the company has developed a monoclonal antibody therapy that has shown in preclinical trials to bind specifically to cancer and virally infected cells targeting the patented tumor maker, destroying the infected cells and leaving all normal cells unharmed.
Immunotherapy using your body's own antibodies can reduce the adverse side effects experienced with current therapies. This would eliminate the need for chemotherapy and radiation treatments and provide a treatment for those cancers that do not currently have one.